Jiangxi Rimag Group Co., Ltd. (HKG:2522)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Medical Labs & Research	928.91M	784.44M	592.01M
Medical Labs & Research Growth	18.42%	32.50%	-
Total	928.91M	784.44M	592.01M
Total Growth	18.42%	32.50%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
China	928.91M	784.44M	592.01M
China Growth	18.42%	32.50%	-
Total	928.91M	784.44M	592.01M
Total Growth	18.42%	32.50%	-

Source: S&P Global Market Intelligence.